Definitions
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- noun A particular
drug used to treatbrain tumors .
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word temozolomide.
Examples
-
A 2005 study of radiotherapy and a drug called temozolomide found that 27% of patients lived more than two years and nearly 20% lived past three years -- more than twice the typical survival time.
-
Currently, a drug called temozolomide is the first-line treatment for glioblastoma in humans.
Science News / Features, Blog Entries, Column Entries, Issues, News Items and Book Reviews 2009
-
Currently, a drug called temozolomide is the first-line treatment for glioblastoma in humans.
Science News / Features, Blog Entries, Column Entries, Issues, News Items and Book Reviews 2009
-
The researchers, based at hospitals in Europe and Canada, gave patients both radiation and a chemotherapy drug called temozolomide for six weeks; patients then continued taking the drug alone five days a month for the following six months.
-
The study cohort was divided into 2 groups, those with and without receiving post-radiotherapy adjuvant chemotherapy such as temozolomide or nitrosourea-based chemotherapy.
-
Patients with metastatic melanoma often are treated off-label with drugs such as temozolomide, which has been approved by the FDA for the treatment of certain types of brain cancer but not for the treatment of metastatic melanoma.
News 2010
-
The trial with temozolomide was conducted by the European Organization for Research and Treatment of cancer and The National cancer Institute of Canada and presented to American Society of Clinical Oncology (ASCO).
-
The median survival in the radiation plus temozolomide group was 14.6 months compared to 12.1 months in the radiation alone group.
-
The trial with temozolomide was conducted by the European Organization for Research and Treatment of cancer and The National cancer Institute of Canada and presented to American Society of Clinical Oncology (ASCO).
-
The median survival in the radiation plus temozolomide group was 14.6 months compared to 12.1 months in the radiation alone group.
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.